Coloplast A/S (COLO-B.CO)

896,20 -4,20 (-0,47%) Al cierre: 04:59PM CEST

Coloplast A/S

Holtedam 1-3
Humlebæk 3050
Denmark
45 49 11 11 11
https://www.coloplast.com

Sector(es): Healthcare
Sector: Medical Instruments & Supplies
Empleados a tiempo completo: 15.751

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Kristian Villumsen	President & CEO	17,5M	N/A	1970
Mr. Anders Lonning-Skovgaard	Executive VP & CFO	9M	N/A	1972
Mr. Allan Rasmussen	Executive Vice President of Global Operations	7,9M	N/A	1967
Mr. Nicolai Buhl Andersen	Executive Vice President of Innovation	7,6M	N/A	1969
Mr. Paul Marcun	Executive Vice President of Growth	9,1M	N/A	1967
Mr. Thomas Barfod	Senior Controller & Employees Representative Director	450k	N/A	1970
Ellen Bjurgert	Vice President of Investor Relations	N/A	N/A	N/A
Dennis Kaysen	Director of Corporate Communications	N/A	N/A	N/A
Dorthe Ronnau	Senior Vice President of People & Culture	N/A	N/A	1966
Mr. Alain Morvan	Senior Vice President of Sales Europe	N/A	N/A	N/A

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en DKK.

Descripción

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.

Gobierno corporativo

El ISS Governance QualityScore de Coloplast A/S, a día 1 de abril de 2024, es 3. Las puntuaciones base son Auditoría: 1; Tablero: 4; Derechos de los accionistas: 9; Compensación: 2.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.